In a report released today, Nik Modi from RBC Capital maintained a Buy rating on The Estée Lauder Companies (EL – Research Report), with a ...
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...
RBC Capital Markets adjusted its price target for Amgen (NASDAQ:AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on the biotechnology firm's stock. The ...
RBC Capital Markets adjusted its outlook on AECOM Technology (NYSE:ACM), raising the firm's price target on the shares to $125 from $124, while reiterating an Outperform rating. The decision came ...
Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA:ESLX) to "outperform," citing strong fundamentals and growth opportunities in the ophthalmology sector. Shares of the ...
Investing.com -- RBC Capital Markets has initiated coverage on Greencore Group (LON:GNC) with an 'outperform' rating, citing the company's improving profitability, growth initiatives, and ...
RBC Capital Markets came in at No. 5 on Dealogic’s 2024 M&A league tables (volume by adviser) while Barrenjoey ranked seventh. Big equity raises in the digital infrastructure sector were a major ...
Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA:ESLX) to "outperform," citing strong fundamentals and growth opportunities in the ophthalmology sector. Shares of the eyewear ...
Investing.com -- RBC Capital Markets in a note dated Friday raised its price target for LVMH (EPA:LVMH) Moët Hennessy Louis Vuitton to €780 from €700 following the Luxury goods company’s ...
The strategic pivot to investment banking in the U.S., which coincided with pulling out of an unsuccessful and capital-intensive foray into the ultra-competitive and regulation-heavy retail banking ...
https://www.tipranks.com/news/the-fly/sarepta-could-be-down-on-patient-death-in-fda-database-says-rbc-capital RBC Capital analyst Brian Abrahams says shares of ...